Literature DB >> 19280203

Prognostic effects of doctor-associated diagnostic delays in osteosarcoma.

Min Suk Kim1, Soo-Yong Lee, Wan Hyeong Cho, Won Seok Song, Jae-Soo Koh, Jun Ah Lee, Ji Young Yoo, Duk Seop Shin, Dae-Geun Jeon.   

Abstract

INTRODUCTION: In this retrospective study, we evaluated to what extent diagnostic delays impact prognosis in osteosarcoma.
MATERIALS AND METHODS: The authors identified 26 osteosarcoma patients who had undergone inappropriate procedure-associated diagnostic delays of more than 45 days after surgery, calculated overall survival rates, and analyzed clinicopathologic characteristics.
RESULTS: Initial clinical impressions were of a benign bone tumor in 15 patients, fracture in 8, and infection in 3. After initial inappropriate procedures, primary surgeons failed to send a tissue sample to a pathologist for definite diagnosis in 12 cases, and pathologists made incorrect diagnoses in the other 14. The average doctor-associated diagnostic delay after inappropriate surgery for these 26 patients was 10.5 months. Following referral to our institute, 22 underwent both surgery and chemotherapy and the remaining 4 patients underwent chemotherapy only. Four of the 26 patients were alive at last follow-ups. Estimated 5- and 10-year overall survival rates were 26 and 10%, respectively.
CONCLUSIONS: The present study shows that doctor-associated diagnostic delay superimposed on an inappropriate primary procedure has a significant detrimental effect on overall survival in osteosarcoma. This study demonstrates that surgeons and pathologists should spare no effort to minimize diagnostic errors and delays.

Entities:  

Mesh:

Year:  2009        PMID: 19280203     DOI: 10.1007/s00402-009-0851-7

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  8 in total

1.  MFH of bone and osteosarcoma show similar survival and chemosensitivity.

Authors:  Dae-Geun Jeon; Won Seok Song; Chang-Bae Kong; Jung Ryul Kim; Soo-Yong Lee
Journal:  Clin Orthop Relat Res       Date:  2010-06-18       Impact factor: 4.176

2.  Biomaterials for Orthopaedic Diagnostics and Theranostics.

Authors:  Marian A Ackun-Farmmer; Clyde T Overby; Brittany E Haws; Regine Choe; Danielle S W Benoit
Journal:  Curr Opin Biomed Eng       Date:  2021-06-08

3.  Evaluation of factors affecting survival rate in primary bone sarcomas with extremity and pelvis involvement.

Authors:  Ömer Sofulu; Bülent Erol
Journal:  Acta Orthop Traumatol Turc       Date:  2020-05       Impact factor: 1.511

4.  Plain radiologic findings and chronological changes of incipient phase osteosarcoma overlooked by primary physicians.

Authors:  Won Seok Song; Dae-Geun Jeon; Wan Hyeong Cho; Chang-Bae Kong; Sang Hyun Cho; Jung Wook Lee; Soo-Yong Lee
Journal:  Clin Orthop Surg       Date:  2014-05-16

5.  Prognostic factors and treatment results of high-grade osteosarcoma in norway: a scope beyond the "classical" patient.

Authors:  Kjetil Berner; Kirsten Sundby Hall; Odd R Monge; Harald Weedon-Fekjær; Olga Zaikova; Øyvind S Bruland
Journal:  Sarcoma       Date:  2015-02-17

6.  The sarcoma diagnostic interval: a systematic review on length, contributing factors and patient outcomes.

Authors:  Vicky Soomers; Olga Husson; Robin Young; Ingrid Desar; Winette Van der Graaf
Journal:  ESMO Open       Date:  2020-02

7.  Organization of Bone Sarcoma Care: A Cross-Sectional European Study.

Authors:  Louren Matthias Goedhart; Andreas Leithner; Paul Christiaan Jutte
Journal:  Orthop Surg       Date:  2020-06-26       Impact factor: 2.071

8.  Identifying the prevalence, trajectory, and determinants of psychological distress in extremity sarcoma.

Authors:  Melissa H Tang; David J Castle; Peter F M Choong
Journal:  Sarcoma       Date:  2015-02-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.